[1]赵耀,张芹,黄新苗,等.新型冠状病毒感染患者心律失常的类型及机制[J].国际心血管病杂志,2023,06:392-395.
点击复制
新型冠状病毒感染患者心律失常的类型及机制(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2023年06期
- 页码:
- 392-395
- 栏目:
- 综述
- 出版日期:
- 2023-11-20
文章信息/Info
- Title:
- -
- Author(s):
- -
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-6583.2023.06.014
- 文献标识码:
- -
- 摘要:
- 新型冠状病毒感染（COVID-19）不仅累及呼吸系统，还会累及肺外器官，尤其 是心血管系统。其中，心律失常是COVID-19 患者潜在的、危及生命的并发症。该文介绍 COVID-19 患者心律失常的类型及机制。
- Abstract:
- -
参考文献/References
[1] Shi S, Qin M, Shen B, et al. Association of cardiac injury with
mortality in hospitalized patients with COVID-19 in Wuhan,
China[J]. JAMA Cardiol, 2020, 5(7):802-810.
[2] Della Rocca DG, Magnocavallo M, Lavalle C, et al. Evidence
of systemic endothelial injury and microthrombosis in
hospitalized COVID-19 patients at different stages of the
disease[J]. J Thromb Thrombolysis, 2021, 51(3):571-576.
[3] Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular
considerations for patients, health care workers, and health
systems during the COVID-19 pandemic[J]. J Am Coll
Cardiol, 2020, 75(18):2352-2371.
[4] Berman JP, Abrams MP, Kushnir A, et al. Cardiac
electrophysiology consultative experience at the epicenter
of the COVID-19 pandemic in the United States[J]. Indian
Pacing Electrophysiol J, 2020, 20(6):250-256.
[5] Ergün B, Ergan B, S?zmen MK, et al. New-onset atrial
fibrillation in critically ill patients with coronavirus disease
2019 (COVID-19)[J]. J Arrhythm, 2021, 37(5):1196-1204.
[6] Peltzer B, Manocha KK, Ying XH, et al. Outcomes and
mortality associated with atrial arrhythmias among patients
hospitalized with COVID-19[J]. J Cardiovasc Electrophysiol,
2020, 31(12):3077-3085.
[7] Musikantow DR, Turagam MK, Sartori S, et al. Atrial
fibrillation in patients hospitalized with COVID-19: incidence,
predictors, outcomes, and comparison to influenza[J]. JACC
Clinelectrophysiol, 2021, 7(9):1120-1130.
[8] Mountantonakis SE, Saleh M, Fishbein J, et al. Atrial
fibrillation is an Independent predictor for in-hospital mortality
in patients admitted with SARS-CoV-2 infection[J]. Heart
Rhythm, 2021, 18(4):501-507.
[9] Wang Y, Wang Z, Tse G, et al. Cardiac arrhythmias in patients
with COVID-19[J]. J Arrhythm, 2020, 36(5):827-836.
[10] Dagher L, Wanna B, Mikdadi G, et al. High-degree
atrioventricular block in COVID-19 hospitalized patients[J].
Europace, 2021, 23(3):451-455.
[11] Chinitz JS, Goyal R, Harding M, et al. Bradyarrhythmias in
patients with COVID-19: marker of poor prognosis?[J]. Pacing
Clin Electrophysiol, 2020, 43(10):1199-1204.
[12] Manolis AS, Manolis AA, Manolis TA, et al. COVID-19
infection and cardiac arrhythmias[J]. Trends Cardiovasc Med,
2020, 30(8):451-460.
[13] Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and
cardiac arrhythmias[J]. Heart Rhythm, 2020, 17(9):1439-1444.
[14] Guo T, Fan YZ, Chen M, et al. Cardiovascular implications
of fatal outcomes of patients with coronavirus disease 2019
(COVID-19)[J]. JAMA Cardiol, 2020, 5(7):811-818.
[15] Lai PH, Lancet EA, Weiden MD, et al. Characteristics
associated with out-of-hospital cardiac arrests and
resuscitations during the novel coronavirus disease 2019
pandemic in New York city[J]. JAMA cardiol, 2020,
5(10):1154-1163.
[16] Bertini M, Ferrari R, Guardigli G, et al. Electrocardiographic
features of 431 consecutive, critically ill COVID-19 patients:
an insight into the mechanisms of cardiac involvement[J].
Europace, 2020, 22(12):1848-1854.
[17] Alareedh M, Nafakhi H, Shaghee F, et al. Electrocardiographic
markers of increased risk of sudden cardiac death in
patients with COVID-19 pneumonia[J]. Ann Noninvasive
Electrocardiol, 2021, 26(3):e12824.
[18] M c C u l l o u g h S A , G o y a l P, K r i s h n a n U , e t a l .
Electrocardiographic findings in coronavirus disease-19:
insights on mortality and underlying myocardial processes[J].
J Card Fail, 2020, 26(7):626-632.
[19] Kariyanna PT, Sutarjono B, Grewal E, et al. A systematic
review of COVID-19 and myocarditis[J]. Am J Med Case Rep,
2020, 8(9):299-305.
[20] Barman HA, Atici A, Alici G, et al. The effect of the severity
COVID-19 infection on electrocardiography[J]. Am J Emerg
Med, 2021, 46:317-322.
[21] Chen L, Feng Y, Tang J, et al. Surface electrocardiographic
characteristics in coronavirus disease 2019: repolarization
abnormalities associated with cardiac involvement[J]. ESC
heart fail, 2020, 7(6):4408-4415.
[22] Santoro F, Monitillo F, Raimondo P, et al. QTc interval
prolongation and life-threatening arrhythmias during
hospitalization in patients with coronavirus disease 2019
(COVID-19): results from a multicenter prospective
registry[J]. Clin Infect Dis, 2021, 73(11):e4031-e4038.
[23] Giudicessi JR, Noseworthy PA, Friedman PA, et al. Urgent
guidance for navigating and circumventing the QTc-prolonging
and torsadogenic potential of possible pharmacotherapies for
coronavirus disease 19 (COVID-19)[J]. Mayo Clin Proc, 2020,
95(6):1213-1221.
[24] Mercuro NJ, Yen CF, Shim DJ, et al. Risk of QT interval
prolongation associated with use of hydroxychloroquine with
or without concomitant azithromycin among hospitalized
patients testing positive for coronavirus disease 2019
(COVID-19)[J]. JAMA Cardiol, 2020, 5(9):1036-1041.
[25] Lindner D, Fitzek A, Br?uninger H, et al. Association of
cardiac infection with SARS-CoV-2 in confirmed COVID-19
autopsy cases[J]. JAMA cardiol, 2020, 5(11):1281-1285.
[26] Vaduganathan M, Vardeny O, Michel T, et al. Reninangiotensin-
aldosterone system inhibitors in patients with
covid-19[J]. N Engl J Med, 2020, 382(17):1653-1659.
[27] Huynh TV, Rethi L, Lee TW, et al. Spike protein impairs
mitochondrial function in human cardiomyocytes: mechanisms
underlying cardiac jnjury in COVID-19[J]. Cells, 2023,
12(6):877.
[28] Huang C, Wang Y, Li XW, et al. Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China[J].
Lancet, 2020, 395(10223):497-506.
[29] Mohanty S, Trivedi C, Della Rocca DG, et al. Thromboembolic
risk in atrial fibrillation patients with left atrial scar postextensive
ablation: a single-center experience[J]. JACC Clin
electrophysiol, 2021, 7(3):308-318.
[30] Nabeh OA, Helaly MM, Menshawey R, et al. Contemporary
approach to understand and manage COVID-19-related
arrhythmia[J]. Egypt Heart J, 2021, 73(1):76.
[31] Siripanthong B, Nazarian S, Muser D, et al. Recognizing
COVID-19-related myocarditis: the possible pathophysiology
and proposed guideline for diagnosis and management[J].
Heart Rhythm, 2020, 17(9):1463-1471.
[32] Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19
mRNA vaccines[J]. Circulation, 2021, 144(6):471-484.
[33] Varney JA, Dong VS, Tsao T, et al. COVID-19 and arrhythmia:
an overview[J]. J Cardiol, 2022, 79(4):468-475.
[34] Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell
infection and endotheliitis in COVID-19[J]. Lancet, 2020,
395(10234):1417-1418.
[35] Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence
of thrombotic complications in critically ill ICU patients with
COVID-19[J]. Thromb Res, 2020, 191:145-147.
[36] Gargano JW, Wallace M, Hadler SC, et al. Use of mRNA
COVID-19 vaccine after reports of myocarditis among
vaccine recipients: update from the advisory committee on
immunization practices—United States, June 2021[J]. MMWR
Morb Mortal Wkly Rep, 2021, 70(27):977-982.
[37] Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19,
arrhythmic risk, and inflammation: mind the gap![J].
Circulation, 2020, 142(1):7-9.
[38] Chen D, Li X, Song Q, et al. Assessment of hypokalemia and
clinical characteristics in patients with coronavirus disease
2019 in Wenzhou, China[J]. JAMA Netw Open, 2020,
3(6):e2011122.
[39] Wu CI, Postema PG, Arbelo E, et al. SARS-CoV-2,
COVID-19, and inherited arrhythmia syndromes[J]. Heart
Rhythm, 2020, 17(9):1456-1462.
[40] Paniri A, Hosseini MM, Rasoulinejad A, et al. Molecular
effects and retinopathy induced by hydroxychloroquine during
SARS-CoV-2 therapy: role of CYP450 isoforms and epigenetic
modulations[J]. Eur J Pharmacol, 2020, 886:173454.
备注/Memo
- 备注/Memo:
-
基金项目：中央军委后勤保障部保健专项（20BJZ11）；上海市“医
苑新星”杰出青年人才计划卓越项目（20224Z0007）
通信作者：黄新苗， E-mail：huangxinmiao@hotmail.com
常用功能
统计/Statistics
- 摘要浏览/Viewed1
- 全文下载/Downloads97
- 评论/Comments
